Steendijk R
Acta Endocrinol Suppl (Copenh). 1986;279:8-12. doi: 10.1530/acta.0.112s008.
A boy is described who was followed from 4 to 21.5 years of age, during which time he was treated with high doses of corticosteroids for a steroid-responsive nephrotic syndrome. For the first 10 years therapy was mainly continuous and height decreased from -0.5 to -4.5 SDS. Later discontinuous treatment without a reduction in the total weekly dose was accompanied by rapid catch-up growth. Final height was -1.0 SDS. During most of the time skeletal age was severely retarded and a discrepancy between the development of the short bones of the hand and the carpal bones was noted.
描述了一名男孩，从4岁到21.5岁接受随访，在此期间他因类固醇反应性肾病综合征接受高剂量皮质类固醇治疗。在最初的10年里，治疗主要是持续的，身高从-0.5 SDS下降到-4.5 SDS。后来采用不减少每周总剂量的间断治疗，伴随着快速追赶生长。最终身高为-1.0 SDS。在大部分时间里，骨骼年龄严重滞后，并且注意到手短骨和腕骨发育之间存在差异。
